A population-based study to develop juvenile arthritis case definitions for administrative health data using model-based dynamic classification.


Journal

BMC medical research methodology
ISSN: 1471-2288
Titre abrégé: BMC Med Res Methodol
Pays: England
ID NLM: 100968545

Informations de publication

Date de publication:
16 05 2021
Historique:
received: 06 10 2020
accepted: 27 04 2021
entrez: 17 5 2021
pubmed: 18 5 2021
medline: 29 6 2021
Statut: epublish

Résumé

Previous research has shown that chronic disease case definitions constructed using population-based administrative health data may have low accuracy for ascertaining cases of episodic diseases such as rheumatoid arthritis, which are characterized by periods of good health followed by periods of illness. No studies have considered a dynamic approach that uses statistical (i.e., probability) models for repeated measures data to classify individuals into disease, non-disease, and indeterminate categories as an alternative to deterministic (i.e., non-probability) methods that use summary data for case ascertainment. The research objectives were to validate a model-based dynamic classification approach for ascertaining cases of juvenile arthritis (JA) from administrative data, and compare its performance with a deterministic approach for case ascertainment. The study cohort was comprised of JA cases and non-JA controls 16 years or younger identified from a pediatric clinical registry in the Canadian province of Manitoba and born between 1980 and 2002. Registry data were linked to hospital records and physician billing claims up to 2018. Longitudinal discriminant analysis (LoDA) models and dynamic classification were applied to annual healthcare utilization measures. The deterministic case definition was based on JA diagnoses in healthcare use data anytime between birth and age 16 years; it required one hospitalization ever or two physician visits. Case definitions based on model-based dynamic classification and deterministic approaches were assessed on sensitivity, specificity, and positive and negative predictive values (PPV, NPV). Mean time to classification was also measured for the former. The cohort included 797 individuals; 386 (48.4 %) were JA cases. A model-based dynamic classification approach using an annual measure of any JA-related healthcare contact had sensitivity = 0.70 and PPV = 0.82. Mean classification time was 9.21 years. The deterministic case definition had sensitivity = 0.91 and PPV = 0.92. A model-based dynamic classification approach had lower accuracy for ascertaining JA cases than a deterministic approach. However, the dynamic approach required a shorter duration of time to produce a case definition with acceptable PPV. The choice of methods to construct case definitions and their performance may depend on the characteristics of the chronic disease under investigation.

Sections du résumé

BACKGROUND
Previous research has shown that chronic disease case definitions constructed using population-based administrative health data may have low accuracy for ascertaining cases of episodic diseases such as rheumatoid arthritis, which are characterized by periods of good health followed by periods of illness. No studies have considered a dynamic approach that uses statistical (i.e., probability) models for repeated measures data to classify individuals into disease, non-disease, and indeterminate categories as an alternative to deterministic (i.e., non-probability) methods that use summary data for case ascertainment. The research objectives were to validate a model-based dynamic classification approach for ascertaining cases of juvenile arthritis (JA) from administrative data, and compare its performance with a deterministic approach for case ascertainment.
METHODS
The study cohort was comprised of JA cases and non-JA controls 16 years or younger identified from a pediatric clinical registry in the Canadian province of Manitoba and born between 1980 and 2002. Registry data were linked to hospital records and physician billing claims up to 2018. Longitudinal discriminant analysis (LoDA) models and dynamic classification were applied to annual healthcare utilization measures. The deterministic case definition was based on JA diagnoses in healthcare use data anytime between birth and age 16 years; it required one hospitalization ever or two physician visits. Case definitions based on model-based dynamic classification and deterministic approaches were assessed on sensitivity, specificity, and positive and negative predictive values (PPV, NPV). Mean time to classification was also measured for the former.
RESULTS
The cohort included 797 individuals; 386 (48.4 %) were JA cases. A model-based dynamic classification approach using an annual measure of any JA-related healthcare contact had sensitivity = 0.70 and PPV = 0.82. Mean classification time was 9.21 years. The deterministic case definition had sensitivity = 0.91 and PPV = 0.92.
CONCLUSIONS
A model-based dynamic classification approach had lower accuracy for ascertaining JA cases than a deterministic approach. However, the dynamic approach required a shorter duration of time to produce a case definition with acceptable PPV. The choice of methods to construct case definitions and their performance may depend on the characteristics of the chronic disease under investigation.

Identifiants

pubmed: 33993875
doi: 10.1186/s12874-021-01296-9
pii: 10.1186/s12874-021-01296-9
pmc: PMC8127203
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105

Subventions

Organisme : CIHR
ID : FDN 143293
Pays : Canada

Références

J Rheumatol. 2004 Feb;31(2):390-2
pubmed: 14760812
Stat Med. 2017 Oct 30;36(24):3858-3874
pubmed: 28762546
Biostatistics. 2008 Jul;9(3):523-39
pubmed: 18209015
Rheumatol Int. 2017 Sep;37(9):1575-1584
pubmed: 28502061
Comput Biol Med. 2018 Oct 1;101:199-209
pubmed: 30195164
BMC Med Inform Decis Mak. 2019 Jan 9;19(1):5
pubmed: 30626381
J Rheumatol. 2013 Jul;40(7):1218-25
pubmed: 23588938
Neurology. 2018 Nov 27;91(22):e2035-e2044
pubmed: 30389894
Rheumatol Int. 2015 Mar;35(3):575-9
pubmed: 25270916
Stat Methods Med Res. 2018 Jul;27(7):2060-2080
pubmed: 27789653
Neurology. 2016 Oct 11;87(15):1557-1564
pubmed: 27629096
Arthritis Rheum. 1977 Mar;20(2 Suppl):195-9
pubmed: 318120
PLoS One. 2015 Mar 24;10(3):e0119186
pubmed: 25803682
BMC Health Serv Res. 2011 Feb 16;11:37
pubmed: 21324188
J Appl Stat. 2012 Jun 1;39(6):1151-1175
pubmed: 22679342
J Biopharm Stat. 2009 Sep;19(5):779-90
pubmed: 20183443
Can J Hosp Pharm. 2015 May-Jun;68(3):232-7
pubmed: 26157185
Hypertension. 2009 Dec;54(6):1423-8
pubmed: 19858407
Biom J. 2018 Mar;60(2):307-322
pubmed: 28833412
J Am Med Inform Assoc. 2013 Dec;20(e2):e349-54
pubmed: 24166724
J Clin Epidemiol. 2010 Dec;63(12):1332-41
pubmed: 20457509
J Am Med Inform Assoc. 2017 Mar 1;24(2):361-370
pubmed: 27521897
Can J Public Health. 2002 Nov-Dec;93 Suppl 2:S57-62
pubmed: 12580392
Annu Rev Public Health. 2001;22:213-30
pubmed: 11274519
Am J Epidemiol. 1999 May 15;149(10):916-24
pubmed: 10342800
Annu Rev Public Health. 2011;32:91-108
pubmed: 21219160
Arthritis Care Res (Hoboken). 2019 Mar;71(3):413-418
pubmed: 29799673
Rheumatol Int. 2015 Feb;35(2):345-50
pubmed: 25023756
J Clin Epidemiol. 2008 Dec;61(12):1250-1260
pubmed: 18619800
Sci Rep. 2018 Jun 15;8(1):9161
pubmed: 29907747
Soc Sci Med. 1997 Aug;45(3):383-97
pubmed: 9232733

Auteurs

Allison Feely (A)

Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, Canada.

Lily Sh Lim (LS)

Department of Paediatrics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.

Depeng Jiang (D)

Department of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, S113-750 Bannatyne Avenue, R3E 0W3, Winnipeg, Canada.

Lisa M Lix (LM)

Department of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, S113-750 Bannatyne Avenue, R3E 0W3, Winnipeg, Canada. lisa.lix@umanitoba.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH